QTRXNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Quanterix Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$2.77−0.10 (-3.48%)
Close on Oct 19, 2026
- Market cap
- $130.65M
- P/E (TTM)
- –
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2015 to 2025
Gross margin
46.8%−9.0 pts over 5 years
Operating margin
-90.4%−53.8 pts over 5 years
Net margin
-77.1%−40.6 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +1.1% | +9.6% | +10.0% | – | |
| Gross profit | -21.8% | +12.7% | +6.2% | – |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | -18.9% | -34.2% | |
| Return on assets | – | -14.3% | -26.0% | |
| Current ratio | – | 5.52 | 2.84 | |
| Debt to equity | – | – | – | |
| Net debt to EBITDA | – | – | – | |
| Inventory turnover | – | 3.0× | 1.7× | |
| Capex to revenue | 3.0% | 4.5% | 1.9% | |
| Diluted shares | 2M | 30M | 43M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Quanterix generated $227.48M from operations and spent $35.11M on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
$227.48M
Used
$35.11M
Capital expenditure$35.11M100%Dividends$00%Share buybacks$00%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin-77.1%
×Asset turnover0.34×
×Equity multiplier1.32×
=Return on equity, FY2025-34.2%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | -77.1% | 0.34× | 1.32× | -34.2% |
| FY2024 | -28.0% | 0.33× | 1.23× | -11.3% |
| FY2023 | -23.2% | 0.28× | 1.22× | -8.0% |
| FY2022 | -94.4% | 0.23× | 1.17× | -24.9% |
| FY2021 | -50.2% | 0.29× | 1.19× | -17.1% |
| FY2020 | -36.5% | 0.39× | 1.32× | -18.9% |
| FY2019 | -71.9% | 0.48× | 1.40× | -48.1% |
| FY2018 | -83.8% | 0.47× | 1.49× | -59.0% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
2of 8 tests passed in fiscal 2025. Some tests lack the figures they need.
- ProfitableNet income above zero-$107.15M
- Cash generatingOperating cash flow above zero-$77.24M
- Return on assets improvedROA up on the prior year-9.0% → -26.4%
- Earnings backed by cashOperating cash flow above net income-$77.24M vs -$107.15M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose8.66 → 2.84
- No dilutionShare count did not rise38M → 43M
- Gross margin improvedGross margin up on the prior year60.47% → 46.77%
- More efficientAsset turnover rose0.32 → 0.34